SIGA Technologies to Sell 1.7M Courses of ST-246 Smallpox Antiviral to National Stockpile

by Patrick Henderson, Benzinga Staff Writer
June 28, 2011 7:15 AM | 11 seconds read |
SIGA SIGA announced that the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services has withdrawn the protest filed against the contract it awarded to the company.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsContractsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!